These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12616982)

  • 1. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus.
    Brussaard HE; Leuven JA; Krans HM; Kluft C
    Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus.
    Hahn L; Mattsson LA; Andersson B; Tengborn L
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):81-6. PubMed ID: 10192656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
    Teede HJ; McGrath BP; Smolich JJ; Malan E; Kotsopoulos D; Liang YL; Peverill RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1404-9. PubMed ID: 10807761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors.
    Gottsäter A; Rendell M; Hulthén UL; Berntorp E; Mattiasson I
    J Intern Med; 2001 Mar; 249(3):237-46. PubMed ID: 11285043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR; Lupoli S; Alves J; Atsumi T; Edwards C; Iannaccone L; Khamashta MA; Hughes GR; Brancaccio V
    Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.
    Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD
    Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
    Schoergenhofer C; Matzneller P; Mußbacher M; Schmid JA; Jilma-Stohlawetz P; Zeitlinger M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1714-1721. PubMed ID: 28796276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH; Schindler AE; Endrikat J; Düsterberg B
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men.
    Kapiotis S; Jilma B; Szalay T; Dirnberger E; Wagner O; Eichler HG; Speiser W
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2861-7. PubMed ID: 9409267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.